Skip to content

Rosuvastatin

Crestor, Ezallor Sprinkle (rosuvastatin) is a small molecule pharmaceutical. Rosuvastatin was first approved as Crestor on 2003-08-12. It is used to treat coronary artery disease, hypercholesterolemia, hyperlipoproteinemias, and hypertriglyceridemia in the USA. It is known to target 3-hydroxy-3-methylglutaryl-Coenzyme A reductase. Crestor's patents are valid until 2036-02-12 (FDA).
Trade Name Crestor, Ezallor Sprinkle
Common Name Rosuvastatin
Indication coronary artery disease, hypercholesterolemia, hyperlipoproteinemias, hypertriglyceridemia
Drug Class Enzyme inhibitors: antihyperlipidemics (HMG-CoA inhibitors)
Rosuvastatin
Get full access now